Holen Sie sich die Stockscreener-App
9.315
1.43%
-0.135
Schlusskurs vom Vortag:
$9.45
Offen:
$9.47
24-Stunden-Volumen:
79,089
Relative Volume:
0.12
Marktkapitalisierung:
$284.15M
Einnahmen:
$40.61M
Nettoeinkommen (Verlust:
$-29.07M
KGV:
-9.2402
EPS:
-1.0081
Netto-Cashflow:
$-26.70M
1W Leistung:
+0.81%
1M Leistung:
-33.32%
6M Leistung:
-13.11%
1J Leistung:
-62.71%
1-Tages-Spanne:
$9.29
$9.58
1-Wochen-Bereich:
$8.95
$9.7195
52-Wochen-Spanne:
$8.27
$28.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
9.315 | 284.15M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
98.70 | 170.80B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.48 | 119.57B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.99 | 113.15B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.20 | 64.05B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.80 | 50.61B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-05-08 | Fortgesetzt | Stifel | Buy |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc.CLPT - GlobeNewswire Inc.
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates - Zacks Investment Research
ClearPoint Neuro Director R. John Fletcher Receives 993 Shares as Director Compensation - Kalkine Media
319 shares go to director Timothy T. Richards as fee payment from ClearPoint Neuro (CLPT). - Stock Titan
ClearPoint Neuro (NasdaqCM:CLPT) Stock Forecast & Analyst Predictions - simplywall.st
Top Conexeu Sciences (CNXU) Competitors 2026 - marketbeat.com
Conexeu Sciences (CNXU) Short Interest & Short Float | Updated Sep 2026 - marketbeat.com
Hemostemix files for price protection in $1M pr... - Pluang
ClearPoint Neuro stock slips as revenue misses estimates - ad-hoc-news.de
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment - Yahoo Finance
ClearPoint Neuro Company Profile & Introduction - Moomoo
How (CLPT) Movements Inform Risk Allocation Models - Stock Traders Daily
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $25 - Moomoo
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - ACCESS Newswire
ClearPoint Neuro stock holds recent gains as earnings and analyst targets frame the next move - AD HOC NEWS
ClearPoint (CLPT) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Finish 11.80% Up on the DaySubscription Growth Report - vinanet.vn
ClearPoint (CLPT) Results at a Glance: The Bottom-Line Figure Trails Its Comparison in the Current Update; Trading Response: Shares Fall 2.01% at the CloseBuyback Announcement Report - vinanet.vn
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Conway Capital Management Inc. Makes New $1.66 Million Investment in ClearPoint Neuro, Inc. $CLPT - MarketBeat
ClearPoint Neuro (CLPT) Edges Lower as Shares Consolidate Between $14.57 Support and $16.11 ResistanceBullish Sentiment - vinanet.vn
ClearPoint Neuro (CLPT) Edges Lower as Shares Consolidate Between $14.57 Support and $16.11 ResistanceBullish Sentiment - vinanet.vn
(CLPT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ClearPoint Neuro (CLPT): MAK Capital group discloses 7.8% ownership in 13G/A - Stock Titan
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - AOL.com
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - The Globe and Mail
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - The Globe and Mail
ClearPoint Neuro (CLPT) Jumps 6.12% to $14.21: Key Levels to WatchSell Signal Alerts - vinanet.vn
ClearPoint Neuro (NASDAQ:CLPT) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Have Lowered Expectations For ClearPoint Neuro, Inc. (NASDAQ:CLPT) After Its Latest Results - 富途牛牛
Clearpoint Neuro Inc (CLPT) Stock News Today - TradingKey
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
Analysts Have Lowered Expectations For ClearPoint Neuro, Inc. (NASDAQ:CLPT) After Its Latest Results - Moomoo
ClearPoint Neuro, Inc. (CLPT) Options Chain - Yahoo! Finance Canada
CLPT Looks 4.6% Overvalued on GF Value™ Ahead of Tuesday Market Drop - GuruFocus
ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case (CLPT) - Seeking Alpha
ClearPoint Neuro Updates Q2 Results and 2026 Outlook - The Globe and Mail
ClearPoint Neuro (CLPT) investors disclose 7.45% beneficial ownership stake - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Cuts Target Price to $25 - Moomoo
Stifel cuts Clearpoint Neuro stock price target on guidance cut - Investing.com
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com South Africa
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com Nigeria
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com India
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks - Benzinga
CLPT Looks 4.7% Overvalued on GF Value™ - GuruFocus
CLPT Looks 4.7% Overvalued on GF Value™ - GuruFocus
How Does ClearPoint Neuro Inc (CLPT) Perform in Q2? EPS at -$0.3 - GuruFocus
Earnings call transcript: Clearpoint Neuro Q2 2026 misses estimates as shares fall - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clearpoint Neuro Inc-Aktie (CLPT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President |
Jun 29 '26 |
Sale |
19.38 |
20,000 |
387,600 |
116,842 |
| BURNETT JOSEPH | CEO and President |
Jun 29 '26 |
Option Exercise |
2.50 |
20,000 |
50,000 |
136,842 |
| JOSEPH BURNETT | Director |
Jun 29 '26 |
Proposed Sale |
18.48 |
20,000 |
369,600 |
0 |
| BURNETT JOSEPH | CEO and President |
Jun 17 '26 |
Option Exercise |
2.50 |
60,000 |
150,000 |
176,842 |
| BURNETT JOSEPH | CEO and President |
Jun 17 '26 |
Sale |
17.79 |
60,000 |
1,067,400 |
116,842 |
| BURNETT JOSEPH | CEO and President |
Jun 17 '26 |
Sale |
17.94 |
1,843 |
33,063 |
191,388 |
| JOSEPH M BURNETT TRUST | Affiliate of Director |
Jun 17 '26 |
Proposed Sale |
13.34 |
1,843 |
24,586 |
0 |
| JOSEPH BURNETT | Director |
Jun 17 '26 |
Proposed Sale |
13.34 |
60,000 |
800,400 |
0 |
| Richards Timothy T. | Director |
Jun 04 '26 |
Option Exercise |
10.00 |
500 |
5,000 |
87,698 |
| Richards Timothy T. | Director |
Jun 01 '26 |
Sale |
12.17 |
5,415 |
65,901 |
87,198 |
1.72%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):